


























































published: 17 December 2013
doi: 10.3389/fped.2013.00043
Myelination of the postnatal mouse cochlear nerve at the
peripheral-central nervous system transitional zone
JueWang1†, Baofu Zhang1†, Hui Jiang1,2†, Lei Zhang1, Danzheng Liu1,3, Xiao Xiao1, Hannah Ma1,
Xuemei Luo1,3, Dennis Bojrab II 1 and Zhengqing Hu1*
1 Department of Otolaryngology-HNS, Wayne State University School of Medicine, Detroit, MI, USA
2 Department of Otolaryngology, Jinshan Hospital, Fudan University, Shanghai, China
3 Department of Otolaryngology, Zhongshan Hospital, Fudan University, Shanghai, China
Edited by:
James Mark Coticchia, Wayne State
University School of Medicine, USA
Reviewed by:
Henrique De Amorim Almeida,
Polytechnic Institute of Leiria, Portugal
Amade Bregy, University of Miami,
USA
Yaying Zhu, Fudan University, China
*Correspondence:
Zhengqing Hu, Department of
Otolaryngology-HNS, Wayne State
University School of Medicine, 550
East Canfield Street 258 Lande,
Detroit, MI 48201, USA
e-mail: zh@med.wayne.edu
†Jue Wang, Baofu Zhang and Hui
Jiang have contributed equally to this
work.
In the nerve roots of vertebrates, the peripheral nervous system (PNS) and central ner-
vous system (CNS) interface at the PNS-CNS transitional zone (PCTZ), which consists of
cell boundaries with various myelin components. We have recently shown that the mouse
cochlear nerve presents an exceptionally long segment of the CNS tissue extending into
the PNS using light microscopy. However, it is unclear how oligodendrocytes and Schwann
cells contribute to the formation of myelin components of the PCTZ. It is undetermined
how myelination is initiated along the cochlear nerve, and when it adopts a mature pattern.
In this study, immunofluorescence using antibodies specific to oligodendrocyte marker
myelin oligodendrocyte glycoprotein (MOG) and Schwann cell marker myelin protein zero
(MPZ) were used to detail the expression of myelin components along the postnatal mouse
cochlear nerve. We found that the expression of MPZ was initially observed in the soma
of bipolar spiral ganglion neurons at postnatal day 0 (P0) and progressed to the central and
peripheral processes after P8–P10. Myelination of the CNS tissue was initiated in close
proximity to the PCTZ from P7 to P8 and then extended centrally. Myelination of the PCTZ
reached a mature style at P14, when the interface of the expression of MOG and MPZ
was clearly identified along the cochlear nerve. This knowledge of PCTZ formation of the
cochlear nerve will be essential to future myelination research, and it will also gain clini-
cal interest because of its relevance to the degeneration and regeneration of the auditory
pathway in hearing impairment.
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INTRODUCTION
In the nervous system of vertebrates, the peripheral nervous sys-
tem (PNS) and central nervous system (CNS) transitional zone
(PCTZ) constitutes the boundary of the CNS and PNS. The PCTZ
of cranial nerves, such as oculomotor, trochlear, and abducent
nerves, is usually dome shaped with the CNS compartment extend-
ing peripherally along the nerve trunks (1, 2). In most nerve roots,
the PCTZ is located within a few millimeters from the CNS sur-
face. The nerve fibers usually continue at the PCTZ, while myelin
components of the CNS and PNS interface to form the PCTZ (3,
4). Oligodendrocytes and Schwann cells are the myelinating glia
of the CNS and PNS respectively, which form unique heminodes
at the PCTZ (5, 6). During development, oligodendrocytes origi-
nate from the neural tube and Schwann cells are derived from the
neural crest, which contribute to the distinct properties of their
morphology and molecular components (7). For example, myelin
protein zero (MPZ) is specifically expressed in Schwann cells
while myelin oligodendrocyte glycoprotein (MOG) is detected in
oligodendrocytes (4).
Cochlear nerve is responsible for auditory signals transferring
from the cochlea to the cochlear nucleus (CN). A light microscopy
study suggested that the rat cochlear nerve presented an excep-
tionally long segment of CNS tissue extending into the PNS, and
the PCTZ located within the internal acoustic meatus (8, 9). Our
recent light microscopy study in the mouse model confirmed
this observation. In addition, we found that the PCTZ of the
mouse cochlear nerve was located within the modiolus at the basal
cochlear turn level (10).
In a previous study using antibodies specific to PNS and CNS
myelin, it was observed that peripheral myelin proteins were
specifically expressed in the segment between the perikaryon of
spiral ganglion neurons and the PCTZ along the cochlear nerve,
while the central type myelin was expressed between the PCTZ and
the brainstem. However, it is unclear how oligodendrocytes and
Schwann cells contribute to the formation of myelin components
along the cochlear nerve. It remains unknown how myelination is
initiated along the cochlear nerve,and when it adopts a mature pat-
tern. In this study,we harvested the postnatal mouse cochlear nerve
and used immunofluorescence analyses to address these questions.
MATERIALS AND METHODS
ANIMAL AND GROUPS
All animal procedures were approved by local Institutional Animal
Care and Use Committee (IACUC). Swiss Webster mice were used
in this study at the following ages: postnatal day 0 (P0, the day of
birth), 1, 3, 5, 7, 8, 10, 14, and 30 of either sex. The tissues from P0
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mice were harvested at approximately 3–4 h after birth. Each age
point comprised of five replicates.
TISSUE HARVEST AND SAMPLE PREPARATION
A novel cochlea-cochlear nerve-CN cryosection model was used
in this study (10). P0–P14 mice were euthanized with decapita-
tion, and P30 mice were euthanized with an overdose of CO2.
The inner ear, brainstem, and the connecting cochlear nerve were
identified and fixed in 4% paraformaldehyde (Sigma) overnight
at 4°C. The specimens from P7 to P30 were treated with 0.1 M
EDTA (Sigma) for approximately 5 days for decalcification. The
samples were incubated in 30% sucrose (Sigma) for cryoprotec-
tion followed by cryosectioned on a cryostat (Leica) at a thickness
of approximately 10µm. The sectioning was started on the sur-
face of round window and parallel to the modiolus. The sections
containing the entire cochlea, the cochlear nerve, and the CN were
collected for the following immunofluorescence study.
IMMUNOFLUORESCENCE STUDY
Cryosections were incubated in PBS containing 5% normal don-
key serum (Jackson ImmunoResearch) and 0.2% Triton X-100
(Sigma) for 30 min, and then in the primary antibodies overnight
at 4°C. The primary antibodies used in this study included mono-
clonal mouse anti-MOG (1:100, Millipore) and chicken anti-MPZ
(1:200, Millipore). Dylight conjugated secondary antibodies (Jack-
son ImmunoResearch) were applied to cryosections for 2 h at room
temperature. The samples were observed using an epifluorescence
microscopy (Leica) or confocal microscopy (Leica).
RESULTS
EXPRESSION OF SCHWANN CELL PROTEIN MPZ
The expression of PNS Schwann cell protein MPZ was detected
at the spiral ganglion area from P0 (Figure 1). During P0–P3, the
expression of MPZ was at very low levels and restricted to the soma
region of spiral ganglion neurons (Figures 1B,D). During P5–P7,
the expression level of MPZ was increased but still confined to
the soma area of spiral ganglion neurons (Figures 2B,E). From
P8 to P10, the expression of MPZ was observed at the peripheral
processes to the organ of Corti and the central processes to the CN
(Figures 2H,K). The expression of MPZ reached a mature pattern
from P14, which was strong around the soma, the peripheral and
central processes of spiral ganglion neurons (Figure 2N). At P30,
MPZ immunostaining was stably observed at spiral ganglion neu-
rons, including the soma area, the peripheral and central processes
(Figure 2Q).
EXPRESSION OF OLIGODENDROCYTE PROTEIN MOG
The expression of the CNS oligodendrocyte protein MOG was
hardly detectable before P5 (Figures 2A,C). MOG expression was
weak on P7 (Figures 2D,F), gradually became stronger from P8 to
P14 (Figures 2G,J,M), and stayed consistent after P14 (Figure 2P).
The expression of MOG in the CNS portion was initially observed
at the distal part of the central projections that was close to the
PCTZ at P7–P8 (Figures 2D,G). During P10–P14, MOG expres-
sion extended centrally toward the CN (Figures 2G,J,M,P) and
obtained a mature pattern after P14.
DETERMINATION OF PCTZ USING OLIGODENDROCYTE AND SCHWANN
CELL MARKERS
Using antibodies for oligodendrocytes and Schwann cells, the
interface of PCTZ was hard to observe before P7 because the
low expression level of MOG and MPZ. At P8, the expression
of MOG and MPZ was increased but a gap existed along the
cochlear nerve between the portions stained with MOG and MPZ
(Figures 2G–I). At P10, the area labeled with MOG and MPZ was
getting closer but did not form an apparent boundary along the
cochlear nerve (Figures 2J–L). At P14, the expression of MOG
and MPZ was strong and formed a distinct boundary along the
FIGURE 1 |The expression of MPZ in the inner ear of postnatal
mouse. (A) A light microscopy image showed the anatomy of
postnatal day 1 (P1) mouse cochlea, spiral ganglion region (arrows),
cochlear nerve, and cochlear nucleus (CN). The myelination of the
cochlear nerve distal to the PCTZ, which was determined by
immunostaining of MPZ [red, arrows in (B–D)], was found around the
soma of the spiral ganglion neurons in P0 (B), P1 (C), and P3 (D) mice.
Scale: 50µm shown in (D).
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FIGURE 2 | Determination of PCTZ formation along the postnatal mouse
cochlear nerve using MOG and MPZ immunostaining. The expression of
MOG was weak and hardly detectable during postnatal days 5–7 (P5–P7)
[arrows in (A), (C), (D), and (F)]. From P8 to P10, the expression of MOG was
increased and located at the level of basal cochlear turn [arrows in (G), (I), (J),
and (L); dotted lines indicate the boundary]. The expression of MOG was
strong and obtained the mature pattern at P14–P30 [arrows in (M), (O), (P),
and (R)]. The expression of MPZ around the spiral ganglion region was weak
on P5 (B), strengthened from P7 to P10 [arrowheads in (E), (H), and (K);
dotted lines indicate the boundary], and held stable after P14 [arrowheads in
(N) and (Q); dotted lines indicate the boundary]. MPZ expression was initially
observed along the cochlear nerve in close proximity to the apical turn of the
cochlea as early as P5 [arrowhead in (B)]. Its expression extended centrally
toward PCTZ from P7 to P10 [arrowheads in (E), (F), (H), (I), (K), and (L)], and
reached the PCTZ after P14 [arrowheads in (N), (O), (Q), and (R)]. Scale:
50µm shown in (R).
cochlear nerve (Figures 2M,O). At P30, the PCTZ interface was
identified by the boundary interfaced with the expression of MOG
and MPZ (Figures 2P–R).
DISCUSSION
In this study, we investigated the formation of myelin components
along the postnatal mouse cochlear nerve using antibodies spe-
cific for the myelin of the PNS and CNS. We found that MPZ was
detected in the soma region of spiral ganglion neurons as early as
P0, while the peripheral and central processes of spiral ganglion
neurons were labeled by MPZ from P8 to P10. Myelination of
the CNS tissue was initiated from P7 to P8 and located in close
proximity to the PCTZ region. The formation of the PCTZ and
myelination of the mouse cochlear nerve reached a mature pattern
after P14.
In a previous study using a rat cochlear nerve model, no
MPZ immunoreaction was observed at P0. On P8, many spiral
ganglion neurons appeared to be surrounded by MPZ immunos-
taining (9). In our mouse model, myelination of the PNS por-
tion of the cochlear nerve, which was formed by Schwann
cells, was observed around the soma of spiral ganglion neu-
rons as early as P0. In this study, it was also observed that
myelination by Schwann cells along the peripheral and cen-
tral processes of the spiral ganglion neurons began around
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P8–P10 and then extended centrally toward the PCTZ. After
P14, myelination of PNS portion of the mouse cochlear nerve
reached a mature state. The reason for this different MPZ expres-
sion pattern between the rat and mouse models is obscure. It
may be related to the species difference, which requires further
investigation.
Our previous study has shown that the CNS tissue extended
an exceptionally long distance along the cochlear nerves into
the inner ear in the rat and mouse models (10). We found
that the mouse PCTZ migrated peripherally from P0 to P5,
from the sub-arachnoid segment of the cochlear nerve to the
internal auditory meatus, and then toward the basal cochlear
turn to reach a mature pattern after P7 (10). In this study,
we found that myelination of the CNS portion of the mouse
cochlear nerve was initiated on P7–P8, which was indicated by
the MOG expression along the central portion of the cochlear
nerve. Myelination of oligodendrocytes was initiated in close
proximity to the PCTZ, then extended centrally to the CN,
and obtained a mature pattern after P14. These results revealed
that the acquisition of mature CNS tissue projection pattern
observed in the light microscopy is consistent with myelina-
tion of the central portion of the cochlear nerve using MOG
immunostaining.
In summary, we found that the expression of MPZ was detected
around the soma of spiral ganglion neurons as early as P0 and at
the peripheral and central processes during P8–P10. Myelination
of CNS projections, which was indicated by MOG immunos-
taining, was initiated in close proximity to the PCTZ at P7–P8.
Understanding of cochlear nerve myelination around the PCTZ
will be helpful for future myelination studies at the molecular lev-
els. Additionally, the knowledge of myelination along the cochlear
nerve has clinical significance owing to its relevance to cochlear
nerve disorders in hearing loss, neurofibromatosis type II, head
injuries, and other inner ear disorders. Moreover, advances in stem
cell technology provide novel opportunities for auditory pathway
regeneration (11, 12). The information on cochlear nerve myelina-
tion and PCTZ formation will therefore assist in developing novel
treatment options for auditory pathway regeneration using stem
cell-based strategies.
AUTHORS CONTRIBUTION
Jue Wang, Baofu Zhang, and Hui Jiang conduct the experiment,
collected the data, revise the manuscript, and approve the final ver-
sion of the paper. Lei Zhang, Danzheng Liu, Xiao Xiao, Hannah
Ma, Xuemei Luo, Dennis Bojrab II, and Zhengqing Hu contribute
to design the experiment, analyze the data, write and revise the
manuscript, and approve the final version of the paper.
ACKNOWLEDGMENTS
This study is supported by the Carls Endowment Trust and the
NIDCD/NIH (R03DC011597).
REFERENCES
1. Fraher JP, Smiddy PF, O’Sullivan VR. The central-peripheral transitional regions
of cranial nerves. Oculomotor nerve. J Anat (1988) 161:103–13.
2. Fraher JP, Smiddy PF, O’Sullivan VR. The central-peripheral transitional regions
of cranial nerves. Trochlear and abducent nerves. J Anat (1988) 161:115–23.
3. Berthold CH, Carlstedt T. Observations on the morphology at the transition
between the peripheral and the central nervous system in the cat. III. Myelinated
fibres in S1 dorsal rootlets. Acta Physiol Scand Suppl (1977) 446:43–60.
4. Jessen KR, Mirsky R. The origin and development of glial cells in peripheral
nerves. Nat Rev Neurosci (2005) 6:671–82. doi:10.1038/nrn1746
5. Fraher JP, Kaar GF. The transitional node of Ranvier at the junction of the cen-
tral and peripheral nervous systems: an ultrastructural study of its development
and mature form. J Anat (1984) 139(Pt 2):215–38.
6. Fraher JP. The transitional zone and CNS regeneration. J Anat (1999)
194(Pt 2):161–82. doi:10.1046/j.1469-7580.1999.19420161.x
7. Jessen KR. Glial cells. Int J Biochem Cell Biol (2004) 36:1861–7. doi:10.1016/j.
biocel.2004.02.023
8. Fraher JP, Delanty FJ. The development of the central-peripheral transitional
zone of the rat cochlear nerve. A light microscopic study. J Anat (1987)
155:109–18.
9. Toesca A. Central and peripheral myelin in the rat cochlear and vestibular nerves.
Neurosci Lett (1996) 221:21–4. doi:10.1016/S0304-3940(96)13273-0
10. Hu Z. Formation of the peripheral-central transitional zone in the postna-
tal mouse cochlear nerve. Otolaryngol Head Neck Surg (2013) 149:296–300.
doi:10.1177/0194599813489663
11. Hu Z, Ulfendahl M, Prieskorn DM, Olivius P, Miller JM. Functional evaluation
of a cell replacement therapy in the inner ear. Otol Neurotol (2009) 30:551–8.
doi:10.1097/MAO.0b013e31819fe70a
12. Hu Z, Ulfendahl M. The potential of stem cells for the restoration of auditory
function in humans. Regen Med (2013) 8:309–18. doi:10.2217/rme.13.32
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest. The Associate Editor J.M. Coticchia and
Review Editor Y. Zhu declares that, despite being affiliated to the same institution
as all authors, the review process was handled objectively and no conflict of interest
exists.
Received: 26 September 2013; paper pending published: 13 November 2013; accepted:
21 November 2013; published online: 17 December 2013.
Citation: Wang J, Zhang B, Jiang H, Zhang L, Liu D, Xiao X, Ma H, Luo X,
Bojrab D II and Hu Z (2013) Myelination of the postnatal mouse cochlear nerve
at the peripheral-central nervous system transitional zone. Front. Pediatr. 1:43. doi:
10.3389/fped.2013.00043
This article was submitted to Pediatric Otolaryngology, a section of the journal Frontiers
in Pediatrics.
Copyright © 2013 Wang, Zhang, Jiang, Zhang, Liu, Xiao, Ma, Luo, Bojrab II and Hu.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums is
permitted, provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Pediatrics | Pediatric Otolaryngology December 2013 | Volume 1 | Article 43 | 4
